Related Experiment Video
Updated: Jul 20, 2026

10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Cerebral metastases--a therapeutic update.
Robert Cavaliere1, David Schiff
1Dardinger Neuro-Oncology Center at The Ohio State University, Columbus, OH, USA.
Nature Clinical Practice. Neurology
|August 26, 2006
Summary
Advances in cancer treatment offer new options for brain metastases. Stereotactic radiosurgery and novel chemotherapies are improving patient care, though optimal strategies require further research.
Area of Science:
- Oncology
- Neurology
- Radiotherapy
Background:
- Cerebral metastases are a frequent complication in cancer patients.
- Whole-brain radiotherapy was the historical standard, with surgery for select cases.
- Recent advancements are transforming the management of brain metastases.
Purpose of the Study:
- To review current and emerging treatment modalities for cerebral metastases.
- To highlight the evolving role of stereotactic radiosurgery and chemotherapy.
- To identify remaining uncertainties in treatment optimization and patient selection.
Main Methods:
- Review of current literature on cerebral metastases treatment.
- Discussion of stereotactic radiosurgery, chemotherapy (temozolomide, etc.), and treatment sensitizers (efaproxiral, etc.).
- Exploration of clinical trials and future therapeutic directions.
Main Results:
- Stereotactic radiosurgery is a key treatment modality.
- Chemotherapy and treatment sensitizers are under active investigation.
- Optimal combination and timing of therapies remain uncertain.
Conclusions:
- The treatment landscape for cerebral metastases is rapidly evolving.
- Understanding treatment efficacy and toxicity is crucial for patient selection.
- Further research is needed to define optimal therapeutic paradigms.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

